You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-EPO Receptor antibody (ab10653)

CodeSizePriceAbpointsAvailability
    
Add to basket
 

  • -

  •   
  •   
  •   

  •  

  •  
  •  

  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab10653? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab10653 has been referenced in 4 publications.

  1. Perrotta S et al. EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors. PLoS One 5: (2010). WB; Human. PubMed: 20700488
  2. Miller CP et al. Evaluating erythropoietin-associated tumor progression using archival tissues from a phase III clinical trial. Stem Cells 27:2353-61 (2009). IHC-P; Human. PubMed: 19544471
  3. Said HM et al. Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo. Radiother Oncol 83:398-405 (2007). PubMed: 17524506
  4. Della Ragione F et al. Erythropoietin receptors on cancer cells: a still open question. J Clin Oncol 25:1812-3; author reply 1815 (2007). WB; Human. PubMed: 17470877

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"